acetyl- Asn- Gln- Glu- Gln- Val- Ser- Pro- Tyr(3- iodo)- Thr- Leu- Leu- Lys- Gly- NC100194

04/01/2007 - "The purpose of this study was to investigate if the presence of excess NC100668 interferes with the biodistribution and blood clot uptake of (99m)Tc-NC100668. "
04/01/2007 - "With the exception of the kidneys, (99m)Tc-NC100668 biodistribution and blood clot uptake are unaffected by the presence of unlabelled NC100668. "
04/01/2007 - "The biodistribution and blood clot uptake of (99m)Tc-NC100668 and [Asn-U-(14)C]NC100668 are similar. "
04/01/2007 - "Apart from some reduction in kidney retention, the biodistribution and uptake of radioactivity into the blood clot were not significantly affected by the presence of up to 1000 times the clinical dose of NC100668. "

11/01/2007 - "NC100668, a new tracer tested for imaging of venous thromboembolism: pharmacokinetics and metabolism in humans."
01/01/2006 - "Nc100668, a new tracer for imaging of venous thromboembolism: disposition and metabolism in rats."
12/27/2005 - "Quantification of NC100668, a new tracer for imaging of venous thromboembolism, in human plasma using reversed-phase liquid chromatography coupled with electrospray ionization ion-trap mass spectrometry."
12/27/2005 - "NC100668 is being developed as a new tracer for radiopharmaceutical imaging of venous thromboembolism. "
11/01/2007 - "The (99m)Tc-complex of NC100668 [Acetyl-Asn-Gln-Glu-Gln-Val-Ser-Pro-Tyr(3-iodo)-Thr-Leu-Leu-Lys-Gly-NC100194] is a new tracer tested for nuclear medical imaging of venous thromboembolism. "

04/01/2007 - "The biodistribution of (99m)Tc-NC100668 at a range of NC100668 doses was studied in normal Wistar rats and those bearing experimentally induced deep venous thrombosis. "